5c6b02f466c9d800043c1174_1.png
SIML Chairman Announcement
October 22, 2019 08:00 ET | SIMLATUS CORPORATION
San Francisco, California, Oct. 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”), Richard Hylen, Chairman and CEO, has made the...
5c6b02f466c9d800043c1174_1.png
SIML Will Design World’s First Hybrid CBD Extraction System
October 18, 2019 08:00 ET | SIMLATUS CORPORATION
San Francisco, California, Oct. 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”) announces today that Proscere Bioscience will...
5c6b02f466c9d800043c1174_1.png
SIML Receives Green-Light to Build and Deliver $24M in CBD Extraction Systems
October 17, 2019 08:00 ET | SIMLATUS CORPORATION
San Francisco, California, Oct. 17, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”) announces today that certifications and...
5c6b02f466c9d800043c1174_1.png
SIML Continues to Pay Off Convertible Notes While Finalizing Delivery of $24M in CBD Orders
September 17, 2019 08:00 ET | SIMLATUS CORPORATION
San Francisco, California, Sept. 17, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”) announces today that between March and August of...
5c6b02f466c9d800043c1174_1.png
SIML Proscere Bioscience in Negotiations With Major Pharmaceutical Company for a $200M Deal
September 11, 2019 08:00 ET | SIMLATUS CORPORATION
Grass Valley, CA, Sept. 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) ("Simlatus" or the "Company") announces today negotiations with a major pharmaceutical...
5c6b02f466c9d800043c1174_1.png
Chairman Richard Hylen Shares Positive Updates with Shareholders
September 09, 2019 08:00 ET | SIMLATUS CORPORATION
SAN FRANCISCO, CA, Sept. 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”), Chairman and CEO, Richard Hylen, announces that growth...
5c6b02f466c9d800043c1174_1.png
SIML – Proscere Bioscience Announces CBD Extraction Expansion
August 27, 2019 08:00 ET | SIMLATUS CORPORATION
San Francisco, California, Aug. 27, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”) announces today that it has finalized...
5c6b02f466c9d800043c1174_1.png
SIML Retires $400,000 in Convertible Debt With Sales Over $20M During the First Half of 2019
August 07, 2019 08:00 ET | SIMLATUS CORPORATION
San Francisco, California, Aug. 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”) today announces that the Company entered into a...
5c6b02f466c9d800043c1174_1.png
SIML Proscere Bioscience Receives $16M CBD Order on New Hybrid System
August 01, 2019 08:00 ET | SIMLATUS CORPORATION
SAN FRANCISCO, CA, Aug. 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”), a holding company currently focused on opportunities in...
5c6b02f466c9d800043c1174_1.png
SIML Proscere Bioscience Positions Long Term Strategy
July 24, 2019 20:59 ET | SIMLATUS CORPORATION
San Francisco, California, July 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”) is a holding company focused on opportunities in...